Literature DB >> 15809340

Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.

Tohru Takaki1, Kazuhiro Fukasawa, Ikuko Suzuki-Takahashi, Kentaro Semba, Masatoshi Kitagawa, Yoichi Taya, Hiroshi Hirai.   

Abstract

D-type cyclin-dependent kinases (Cdk4 and Cdk6) regulate the G1 to S phase progression of the mammalian cell cycle. It has been suggested that Cdk4 and Cdk6 may have distinct functions in vivo, even though they are indistinguishable biochemically. Here we show that although these Cdks phosphorylate multiple residues in pRB, they do so with different residue selectivities in vitro; Thr821 and Thr826 are preferentially phosphorylated by Cdk6 and Cdk4, respectively. This raises the possibility different substrate specificities lead to their different roles in the regulation of cellular events. Furthermore, our results indicate the new concept that Cdk itself contributes to substrate recognition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809340     DOI: 10.1093/jb/mvi050

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  20 in total

1.  Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.

Authors:  Xian Wang; Christopher Sistrunk; Marcelo L Rodriguez-Puebla
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

2.  CDC25A targeting by miR-483-3p decreases CCND-CDK4/6 assembly and contributes to cell cycle arrest.

Authors:  T Bertero; C Gastaldi; I Bourget-Ponzio; B Mari; G Meneguzzi; P Barbry; G Ponzio; R Rezzonico
Journal:  Cell Death Differ       Date:  2013-02-22       Impact factor: 15.828

3.  Discrete phosphorylated retinoblastoma protein isoform expression in mouse tooth development.

Authors:  Weibo Zhang; Betsy Vazquez; Viktoria Andreeva; Daisy Spear; Elizabeth Kong; Philip W Hinds; Pamela C Yelick
Journal:  J Mol Histol       Date:  2012-04-04       Impact factor: 2.611

4.  Limited redundancy in phosphorylation of retinoblastoma tumor suppressor protein by cyclin-dependent kinases in acute lymphoblastic leukemia.

Authors:  Nicole M R Schmitz; Andreas Hirt; Markus Aebi; Kurt Leibundgut
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 5.  The retinoblastoma tumor-suppressor gene, the exception that proves the rule.

Authors:  D W Goodrich
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

6.  Targeting CDK6 and BCL2 Exploits the "MYB Addiction" of Ph+ Acute Lymphoblastic Leukemia.

Authors:  Marco De Dominici; Patrizia Porazzi; Angela Rachele Soliera; Samanta A Mariani; Sankar Addya; Paolo Fortina; Luke F Peterson; Orietta Spinelli; Alessandro Rambaldi; Giovanni Martinelli; Anna Ferrari; Ilaria Iacobucci; Bruno Calabretta
Journal:  Cancer Res       Date:  2017-12-12       Impact factor: 12.701

7.  p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells.

Authors:  Ling Cen; Brett L Carlson; Mark A Schroeder; Jamie L Ostrem; Gaspar J Kitange; Ann C Mladek; Stephanie R Fink; Paul A Decker; Wenting Wu; Jung-Sik Kim; Todd Waldman; Robert B Jenkins; Jann N Sarkaria
Journal:  Neuro Oncol       Date:  2012-06-18       Impact factor: 12.300

Review 8.  RB1, development, and cancer.

Authors:  Meenalakshmi Chinnam; David W Goodrich
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

9.  The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.

Authors:  Sabine Paternot; Bianca Colleoni; Xavier Bisteau; Pierre P Roger
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein.

Authors:  Simon M Carr; Shonagh Munro; Benedikt Kessler; Udo Oppermann; Nicholas B La Thangue
Journal:  EMBO J       Date:  2010-11-30       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.